This FOA provides resources to support (a) pilot or feasibility studies of new or adapted interventions to prevent HIV infection among populations where substance use may be a contributing factor; (b) pilot or feasibility studies of new or adapted interventions to improve the care of HIV infection among
populations where substance use is prevalent, including interventions that integrate treatment for substance use disorders and HIV infection; or (c) pilot or feasibility studies to increase the scale, uptake, delivery, and/or quality of HIV prevention or care interventions with established evidence of efficacy.
Both primary and secondary prevention will be supported.
The full range of substance use will be considered including problematic episodic use and substance use disorders, as well as a full range of substances and modes of administration.
The most important consideration is that substance use may affect transmission directly as in the case of injection or may affect transmission risk behavior.
Domestic and overseas populations will be considered, with particular attention to populations with disproportionate burden of HIV infection and those where HIV infection and/or drug use are emergent.